ArticleOncotarget2017
The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy.
Katarzyna J Nytko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it